![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Open public recruiting |
Unique ID issued by UMIN | UMIN000048079 |
Receipt No. | R000052729 |
Scientific Title | Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases |
Date of disclosure of the study information | 2022/06/16 |
Last modified on | 2022/06/16 |
Basic information | ||
Public title | Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases | |
Acronym | COMPROMISE study | |
Scientific Title | Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases | |
Scientific Title:Acronym | COMPROMISE study | |
Region |
|
Condition | ||
Condition | Inflammatory bowel disease | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To compare the efficacy of prostaglandin-E major urinary metabolite (PGE-MUM) with other biomarkers (including leucin rich alfa glycoprotein and fecal calprotectin) for the determination of the activity of inflammatory bowel disease |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | Confirmatory |
Trial characteristics_2 | Others |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | To analyze the equality of the accuracy of PGE-MUM for the determination of activity of inflammatory bowel disease with leucin rich alfa glycoprotein and fecal calprotectin. |
Key secondary outcomes |
Base | |
Study type | Others,meta-analysis etc |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Patients with ulcerative colitis or crohn's disease, who scheduled to undergo colonoscopy or small intestinal endoscopy. | |||
Key exclusion criteria | Patients with:
post total colectomy, post intestinal surgery within 6 months, using oral purgatives using nonsteroidal anti-inflammatory drugs, using medication associated with prostaglandin, severe renal dysfuntion |
|||
Target sample size | 150 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | The Jikei University School of Medicine | ||||||
Division name | Division of Gastroenterology and Hepatology | ||||||
Zip code | 105-8461 | ||||||
Address | 3-25-8, Nishi-shinbasshi, Minato-ku | ||||||
TEL | +81334331111 | ||||||
m.saruta@jikei.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | The JIKEI university school of medicine | ||||||
Division name | Division of Gastroenterology and Hepatology | ||||||
Zip code | 105-8461 | ||||||
Address | 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
TEL | +81334331111 | ||||||
Homepage URL | |||||||
to-sakurai@jikei.ac.jp |
Sponsor | |
Institute | The Jikei University School of Medicine |
Institute | |
Department |
Funding Source | |
Organization | The Jikei University School of Medicine |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | The JIKEI university school of medicine |
Address | 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo |
Tel | +81334331111 |
to-sakurai@jikei.ac.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 東京慈恵会医科大学附属病院 |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Open public recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | Cross-sectional study |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052729 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |